• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

均匀单(125)I -胰岛素。单(125)I -(酪氨酰A14) -和单(125)I -(酪氨酰A19) -胰岛素的制备与表征

Homogeneous mono-(125)i-insulins. Preparation and characterization of mono-(125)i-(tyr a14)-and mono-(125)i-(tyr a19)-insulin.

作者信息

Jørgensen K H, Larsen U D

出版信息

Diabetologia. 1980;19(6):546-54. doi: 10.1007/BF00253183.

DOI:10.1007/BF00253183
PMID:7007134
Abstract

Mono-(125)I-(Tyr A19)-insulin (MonoA19) was prepared by iodinating MC porcine insulin with (125)I in acid medium using iodate (as oxidizing agent), followed by anion-exchange chromatography. Mono-(125)I-(Tyr A14)-insulin (MonoA14) was prepared by iodinating MC porcine insulin with (125)I, using H(2)O(2)/lactoperoxidase at neutral pH, followed by anion-exchange chromatography. The specific radioactivities were in the ranges of 120-200 and 220-300 mCi/mg for MonoA19 and MonoA14, respectively. Analyses of the intramolecular distributions of (125)I demonstrated that the preparations were 97-98% radiochemically pure. In both preparations, 98-99% of the radioactivity was capable of binding to insulin antibodies for up to 6 months of storage of the tracers. The IRI concentration decreased with the duration of storage. The greatest observed fall in IRI concentration was 70%. The ime course could be explained by the assumption that the disintegration of a (125)I-nucleus destroys the immunoreactivity of the insulin molecule in which the decay occurs.

摘要

单 -(125)I -(酪氨酸A19)-胰岛素(MonoA19)是通过在酸性介质中使用碘酸盐(作为氧化剂)用(125)I对MC猪胰岛素进行碘化,随后进行阴离子交换色谱法制备的。单 -(125)I -(酪氨酸A14)-胰岛素(MonoA14)是在中性pH下使用H₂O₂/乳过氧化物酶用(125)I对MC猪胰岛素进行碘化,随后进行阴离子交换色谱法制备的。MonoA19和MonoA14的比放射性分别在120 - 200和220 - 300 mCi/mg范围内。对(125)I的分子内分布分析表明,这些制剂的放射化学纯度为97 - 98%。在这两种制剂中,98 - 99%的放射性在示踪剂储存长达6个月的时间内能够与胰岛素抗体结合。IRI浓度随储存时间而降低。观察到的IRI浓度最大下降为70%。这种时间进程可以通过以下假设来解释,即(125)I核的衰变会破坏发生衰变的胰岛素分子的免疫反应性。

相似文献

1
Homogeneous mono-(125)i-insulins. Preparation and characterization of mono-(125)i-(tyr a14)-and mono-(125)i-(tyr a19)-insulin.均匀单(125)I -胰岛素。单(125)I -(酪氨酰A14) -和单(125)I -(酪氨酰A19) -胰岛素的制备与表征
Diabetologia. 1980;19(6):546-54. doi: 10.1007/BF00253183.
2
Tyrosine A14[125I]monoiodoinsulin: Preparation, Biologic Properties, and long-term stability.酪氨酸A14[125I]单碘胰岛素:制备、生物学特性及长期稳定性
Diabetes. 1981 Jan;30(1):1-8. doi: 10.2337/diab.30.1.1.
3
[Heterogeneity of the immunoreactivity of A14, A19, B16 and B26- (125I) monoiodoinsulin to different species of anti-insulin immuno sera].[A14、A19、B16和B26-(125I)单碘胰岛素对不同种类抗胰岛素免疫血清的免疫反应性的异质性]
Hua Xi Yi Ke Da Xue Xue Bao. 1993 Dec;24(4):369-72.
4
Effect of iodination site on binding of radiolabeled ligand by insulin antibodies and insulin autoantibodies.碘化位点对放射性标记配体与胰岛素抗体及胰岛素自身抗体结合的影响。
Clin Chem. 1988 Feb;34(2):356-9.
5
Separation, isolation and characterization of the four monoiodinated insulin tracers using reversed-phase high-performance liquid chromatography.使用反相高效液相色谱法对四种单碘化胰岛素示踪剂进行分离、纯化及表征。
J Chromatogr. 1983 Aug 19;265(2):301-9. doi: 10.1016/s0021-9673(01)96725-1.
6
Monoiodoinsulin specifically substituted in Tyr A14 or Tyr A19.
Int J Pept Protein Res. 1980 May;15(5):495-502. doi: 10.1111/j.1399-3011.1980.tb02927.x.
7
[Radioligand assay: methods and application. V. Mono-125I-insulin: preparation and immunological and biological characterization].[放射性配体分析:方法与应用。V. 单 - 125I - 胰岛素:制备及免疫学和生物学特性鉴定]
Acta Biol Med Ger. 1980;39(4):495-502.
8
The degradation of monoiodotyrosyl insulin isomers by insulin protease.胰岛素蛋白酶对单碘酪氨酰胰岛素异构体的降解作用。
Endocrinology. 1984 Aug;115(2):591-9. doi: 10.1210/endo-115-2-591.
9
Monoiodoinsulin labelled in tyrosine residue 16 or 26 of the insulin B-chain. Preparation and characterization of some binding properties.胰岛素B链酪氨酸残基16或26处标记的单碘胰岛素。一些结合特性的制备与表征
Hoppe Seylers Z Physiol Chem. 1981 Jun;362(6):573-9. doi: 10.1515/bchm2.1981.362.1.573.
10
Preparation of iodine-125-labeled insulin for radioimmunoassay: comparison of lactoperoxidase and chloramine-T iodination.用于放射免疫分析的碘-125标记胰岛素的制备:乳过氧化物酶和氯胺-T碘化法的比较
J Nucl Med. 1978 Aug;19(8):900-5.

引用本文的文献

1
Use of cross-reactivity immunoassay to orient insulin replacement in diabetic patients with high levels of insulin antibodies.使用交叉反应免疫测定法指导胰岛素抗体水平高的糖尿病患者的胰岛素替代治疗。
MethodsX. 2016 Aug 5;3:502-7. doi: 10.1016/j.mex.2016.08.003. eCollection 2016.
2
Design of the novel protraction mechanism of insulin degludec, an ultra-long-acting basal insulin.新型胰岛素德谷胰岛素(一种超长效基础胰岛素)持续释放机制的设计。
Pharm Res. 2012 Aug;29(8):2104-14. doi: 10.1007/s11095-012-0739-z. Epub 2012 Apr 7.
3
Biochemical and physiological properties of a novel series of long-acting insulin analogs obtained by acylation with cholic acid derivatives.

本文引用的文献

1
Protein measurement with the Folin phenol reagent.使用福林酚试剂进行蛋白质测定。
J Biol Chem. 1951 Nov;193(1):265-75.
2
Enzymatic iodination of polypeptides with 125I to high specific activity.用¹²⁵I对多肽进行酶促碘化以获得高比活度。
Biochim Biophys Acta. 1971 Dec 28;251(3):363-9. doi: 10.1016/0005-2795(71)90123-1.
3
Monoiodoinsulin specifically substituted in Tyr A14 or Tyr A19.
Int J Pept Protein Res. 1980 May;15(5):495-502. doi: 10.1111/j.1399-3011.1980.tb02927.x.
通过用胆酸衍生物进行酰化反应得到的一系列新型长效胰岛素类似物的生化和生理特性。
Pharm Res. 2006 Jan;23(1):49-55. doi: 10.1007/s11095-005-9047-1. Epub 2006 Dec 21.
4
Albumin binding of insulins acylated with fatty acids: characterization of the ligand-protein interaction and correlation between binding affinity and timing of the insulin effect in vivo.脂肪酸酰化胰岛素的白蛋白结合:配体 - 蛋白质相互作用的表征以及体内结合亲和力与胰岛素作用时间的相关性。
Biochem J. 1995 Dec 15;312 ( Pt 3)(Pt 3):725-31. doi: 10.1042/bj3120725.
5
Chloroquine augments the binding of insulin to its receptor.氯喹增强胰岛素与其受体的结合。
Biochem J. 1995 Nov 1;311 ( Pt 3)(Pt 3):787-95. doi: 10.1042/bj3110787.
6
Adipocyte insulin binding and insulin sensitivity in 'brittle' diabetes.“脆性”糖尿病患者的脂肪细胞胰岛素结合与胰岛素敏感性
Diabetologia. 1984 Oct;27(4):441-6. doi: 10.1007/BF00273908.
7
Pancreatic A and B cell hyperfunction in the Mendenhall syndrome.门登霍尔综合征中的胰腺A细胞和B细胞功能亢进。
Diabetologia. 1983 Jul;25(1):8-12. doi: 10.1007/BF00251888.
8
Insulin antibody determination: theoretical and practical considerations.胰岛素抗体测定:理论与实践考量
Diabetologia. 1983 Jun;24(6):399-403. doi: 10.1007/BF00257336.
9
Glucose transport and metabolism in adipocytes from newly diagnosed untreated insulin-dependent diabetics. Severely impaired basal and postinsulin binding activities.新诊断未经治疗的胰岛素依赖型糖尿病患者脂肪细胞中的葡萄糖转运与代谢。基础及胰岛素结合后活性严重受损。
J Clin Invest. 1985 Dec;76(6):2091-6. doi: 10.1172/JCI112213.
10
Degradation of endocytosed insulin in rat liver is mediated by low-density vesicles.大鼠肝脏中内吞胰岛素的降解由低密度囊泡介导。
Biochem J. 1985 May 15;228(1):137-46. doi: 10.1042/bj2280137.
4
A convenient preparation of reduced and S-sulfonated A and B chains of insulin.胰岛素A链和B链的还原型及S-磺化型的简便制备方法。
Biochim Biophys Acta. 1966 Sep 26;127(1):246-9. doi: 10.1016/0304-4165(66)90498-3.
5
Monoiodoinsulin: demonstration of its biological activity and binding to fat cells and liver membranes.单碘胰岛素:其生物活性及与脂肪细胞和肝细胞膜结合的证明
Biochem Biophys Res Commun. 1971 Apr 16;43(2):400-8. doi: 10.1016/0006-291x(71)90767-4.
6
The effect of iodination of particular tyrosine residues on the hormonal activity of insulin.特定酪氨酸残基碘化对胰岛素激素活性的影响。
Biochem J. 1972 Jan;126(1):123-31. doi: 10.1042/bj1260123.
7
Monoiodoinsulin. Preparation, purification, and characterization of a biologically active derivative substituted predominantly on tyrosine A14.单碘胰岛素。主要在酪氨酸A14位取代的生物活性衍生物的制备、纯化及特性研究
J Biol Chem. 1974 Jan 10;249(1):21-32.
8
Determination of total serum insulin (IRI) in insulin-treated diabetic patients.胰岛素治疗的糖尿病患者血清总胰岛素(IRI)的测定。
Diabetologia. 1972 Aug;8(4):260-6. doi: 10.1007/BF01225569.
9
Preparation and properties of (monoiodotyrosine)-insulin.(单碘酪氨酸)胰岛素的制备与性质
Biochem J. 1972 Nov;130(1):321-4. doi: 10.1042/bj1300321.
10
About insulin iodination. II. Comparative study of enzymic and chemical methods.
Biochimie. 1974;56(9):1191-6. doi: 10.1016/s0300-9084(74)80010-6.